2018
DOI: 10.2217/bmt-2017-0013
|View full text |Cite
|
Sign up to set email alerts
|

Abstract: Practice pointsr Latinas with breast cancer have been associated with lower prevalence and higher mortality rates. r The access to healthcare system for Latinas has been described as lower than for white women. r Rates of grade III and triple-negative phenotype breast cancer are higher for Latinas than for white women. r BRCA mutation prevalence appears to be higher in Latinas than white women in the American population. r Distribution of BRCA mutation differs by country in Central, Latin America or Caribbean … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
6
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(7 citation statements)
references
References 93 publications
1
6
0
Order By: Relevance
“…Regarding stage of diagnosis between different races, less Hispanics were diagnosed with stage I lesions than white women, supporting prior studies reporting later stages at diagnosis for Hispanic 25,36 women.…”
Section: Discussionsupporting
confidence: 81%
See 3 more Smart Citations
“…Regarding stage of diagnosis between different races, less Hispanics were diagnosed with stage I lesions than white women, supporting prior studies reporting later stages at diagnosis for Hispanic 25,36 women.…”
Section: Discussionsupporting
confidence: 81%
“…While pathologic differences in breast cancer have been noted, the etiology has not been definitively elucidated. Estrogen exposure variation, [22][23][24][25] influenced by cultural norms, may play a role. For example, estrogen exposure fluctuates with parity and duration of breastfeeding, impacting the prevalence of more aggressive phenotypes of breast [22][23][24][25] cancers.…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…Part of these disparities is because women from low-income countries have a delay in cancer management and are diagnosed with more advanced stages. However, different publications also describe that rates of aggressive tumor features have a higher prevalence in some races (Castaneda et al 2018).…”
Section: Introductionmentioning
confidence: 99%